Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia

Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia

Objective: Several clinical scoring systems have been developed for the differential diagnosis of thrombotic microangiopathies (TMAs), all to predict and identify patients with ADAMTS13 deficiency and to start treatment as soon as possible. The first scoring system in this regard was the Bentley sco...

Full description

Bibliographic Details
Main Authors:	Mehmet Baysal, Elif Ümit, Hakkı Onur Kırkızlar, Ahmet Muzaffer Demir
Format:	Article
Language:	English
Published:	Galenos Publishing House 2021-02-01
Series:	Turkish Journal of Hematology
Subjects:	thrombotic thrombocytopenic purpura plasmic score thrombotic microangiopathy french score bentley score
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-26428

Similar Items

Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores
by: Mehmet Baysal, et al.
Published: (2023-12-01)

Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome
by: Nicolas Fage, et al.
Published: (2022-02-01)

The perfect storm: Thrombotic thrombocytopenic purpura (TTP) associated with COVID‐19, a clinical case series and review
by: Neumann Melissa, et al.
Published: (2022-11-01)

Application of PLASMIC Score in Risk Prediction of Thrombotic Thrombocytopenic Purpura: Real-World Experience From a Tertiary Medical Center in Taiwan
by: Chun-Hui Lee, et al.
Published: (2022-05-01)

Traversing Their Path to the Peripheral Smear: The Journey of Traumatized Red Blood Cells
by: Chethana Mannem, et al.
Published: (2023-09-01)

COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
by: Brian Warnecke, et al.
Published: (2023-01-01)

An insidious presentation of thrombotic thrombocytopenic purpura: A case report and brief literature review
by: Shafeek Kiblawi, et al.
Published: (2014-01-01)

Thrombotic thrombocytopenic purpura (TTP) or Moschowitz syndrome: a true hematologic emergency
by: Deborah Melis, et al.
Published: (2012-01-01)

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study
by: Wolfgang Miesbach, et al.
Published: (2019-11-01)

Fatal microangiopathic hemolytic anemia: Two case reports
by: Majed Abdul Basit Momin, et al.
Published: (2018-01-01)

Hereditary Thrombotic Thrombocytopenic Purpura
by: Sanober Nusrat, et al.
Published: (2023-10-01)

The manifestation’s feature of atypical hemolytic uremic syndrome using eculizumab (clinical case)
by: N.N. Guranova, et al.
Published: (2021-09-01)

Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune‐mediated thrombotic thrombocytopenic purpura in the United States
by: Ayoade Adeyemi, et al.
Published: (2022-08-01)

Clinical characteristics, treatments, and outcomes of thrombotic thrombocytopenic purpura treated with plasma exchange in Japan: a nationwide inpatient database study
by: Yuji Yamada, et al.
Published: (2023-05-01)

TTP-like syndrome and its relationship with complement activation in critically ill patients with COVID-19: A cross-sectional study
by: Mohammadreza Ardalan, et al.
Published: (2023-06-01)

Two ischemic stroke events within 48 h: a case report of an unusual presentation of thrombotic thrombocytopenic purpura
by: Melika Jameie, et al.
Published: (2023-01-01)

Cancer‐related thrombotic microangiopathy and disseminated intravascular coagulation in a patient with bone marrow carcinomatosis of unknown primary origin: A case report
by: Masahiro Manabe, et al.
Published: (2024-03-01)

A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke
by: Mark E. Pepin, et al.
Published: (2021-10-01)

Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing
by: Clémence Merlen, et al.
Published: (2022-08-01)

Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship
by: Sruthi Selvakumar, et al.
Published: (2023-02-01)

A Case of Acquired Thrombotic Thrombocytopenic Purpura: Three Recurrences in 25 Years
by: Şinasi Özsoylu
Published: (2015-07-01)

The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review
by: Adrien Joseph, et al.
Published: (2023-04-01)

Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review
by: Adriana Mocanu, et al.
Published: (2023-03-01)

Thrombotic microangiopathies: First report of 294 cases from a single institution experience in Argentina
by: Célia Dos Santos, et al.
Published: (2021-05-01)

Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship
by: Senthil Sukumar, et al.
Published: (2021-12-01)

Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study
by: Nicolas Henry, et al.
Published: (2021-02-01)

Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies—what intensivists need to know
by: Jean-Louis Vincent, et al.
Published: (2018-06-01)

Economic impact of a rapid, on‐demand ADAMTS‐13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura
by: Alicia White, et al.
Published: (2022-05-01)

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
by: Tommaso Mazzierli, et al.
Published: (2023-01-01)

Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection
by: Shuqin Mei, et al.
Published: (2022-12-01)

Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study
by: Cai Yue, et al.
Published: (2020-08-01)

Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
by: I. Mancini, et al.
Published: (2022-06-01)

Presumptive thrombotic thrombocytopenic purpura following a hump-nosed viper (Hypnale hypnale) bite: a case report
by: Milinda Withana, et al.
Published: (2014-08-01)

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
by: Robert W. Maitta, et al.
Published: (2021-11-01)

Successful use of a second course of caplacizumab in relapsed thrombotic thrombocytopenic purpura
by: Jon Shaffer, et al.
Published: (2022-07-01)

Relapsing thrombotic thrombocytopenic purpura with low ADAMTS13 antigen levels: An indication for splenectomy?
by: Anna Maria Lombardi, et al.
Published: (2019-03-01)

Vaccination and Thrombotic Thrombocytopenic Purpura
by: İrfan Yavaşoğlu
Published: (2020-08-01)

Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management
by: Mustafa N. Yenerel
Published: (2014-08-01)

Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia
by: Emine Hidayet, et al.
Published: (2022-06-01)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01)